New findings reveal that rheumatoid arthritis (RA) disease activity significantly affects the severity of interstitial lung disease (ILD), both radiologically and physiologically, in patients with RA ...

Patients with rheumatoid arthritis (RA) and RA-interstitial lung disease are at an increased risk of lung cancer, according to the results of a retrospective, matched cohort study. "Prior studies have ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and ...

Please provide your email address to receive an email when new articles are posted on . Eight clusters of related biomarkers were significantly associated with RA-ILD. The biomarkers led to a greater ...

Rheumatoid arthritis (RA) is linked with over a 50% increased risk for lung cancer, with those having RA-associated interstitial lung disease (RA-ILD) being particularly vulnerable, facing nearly a ...

RA-ILD significantly increases mortality, with a median survival of less than 3 years post-diagnosis. Key risk factors include male gender, older age, smoking, pulmonary comorbidities, rheumatoid ...

A group of peripheral biomarker signatures improved interstitial lung disease (ILD) discrimination beyond clinical risk factors alone in a large cohort of people with rheumatoid arthritis (RA). That's ...

A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and RA-ILD. The study involved over 2500 US veterans and showed strong associations ...

Analysis included 72,795 Veterans Health Administration patients with RA and 633,937 matched non-RA persons. HealthDay News — Rheumatoid arthritis (RA) is associated with a significantly increased ...

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary ...